Status:
COMPLETED
Side-specific Factors for Intraoperative Hemodynamic Instability in Pheochromocytoma
Lead Sponsor:
Zagazig University
Conditions:
adrenalDisease
Eligibility:
All Genders
18+ years
Brief Summary
The performance of adrenalectomy for pheochromocytoma (PHEO) presents significant challenges due to the presence of elevated intraoperative hemodynamic instability (HI) and conversion risk. The object...
Detailed Description
Pheochromocytoma (PHEO) is a malignancy characterized by the production of catecholamines from chromaffin cells located in the adrenomedullary system. The prevalence of PHEO in the general population ...
Eligibility Criteria
Inclusion
- \- patients \>18 years, both sex with unilateral PHEO of any size who underwent TLA
Exclusion
- Patients who have undergone initial open adrenalectomy, various surgical procedures during total laparoscopic adrenalectomy (TLA), complete adrenalectomy,
- bilateral PHEOS bleeding diathesis, skeletal deformity, pregnancy, previous homolateral abdominal surgery, missing data, questionable preoperative diagnosis, inherited PHEO, or recurrent PHEO.
Key Trial Info
Start Date :
September 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2023
Estimated Enrollment :
171 Patients enrolled
Trial Details
Trial ID
NCT06064370
Start Date
September 1 2016
End Date
September 1 2023
Last Update
June 11 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.